Knights of Columbus Asset Advisors’s Novo Nordisk NVO Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Sell	2,931 -1,562	-35%	-$67.1K	0.01%	355
2026 Q1	$165K	Hold	4,493	–	–	0.01%	352
2025 Q4	$229K	Hold	4,493	–	–	0.01%	341
2025 Q3	$249K	Buy	4,493 +107	+2%	+$6.26K	0.01%	319
2025 Q2	$303K	Hold	4,386	–	–	0.02%	296
2025 Q1	$305K	Sell	4,386 -212	-5%	-$17.5K	0.02%	282
2024 Q4	$396K	Buy	4,598 +380	+9%	+$41.1K	0.03%	275
2024 Q3	$502K	Buy	4,218 +802	+23%	+$107K	0.03%	271
2024 Q2	$488K	Hold	3,416	–	–	0.03%	296
2024 Q1	$439K	Buy	3,416 +1,274	+59%	+$152K	0.03%	281
2023 Q4	$222K	Buy	2,142 +1,070	+100%	+$106K	0.01%	310
2023 Q3	$97.5K	Buy	1,072 +52	+5%	+$4.58K	0.01%	344
2023 Q2	$82.5K	Buy	+1,020	New	+$83.3K	0.01%	350

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Knights of Columbus Asset Advisors's NVO Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its Novo Nordisk (NVO) stake by 35% in Q2 2026, selling an estimated $67.1K and leaving 2,931 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #355.

Knights of Columbus Asset Advisors first reported a position in NVO in Q2 2023 and has held it in 13 quarters since. The position peaked at $502K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Knights of Columbus Asset Advisors held 2,931 shares of Novo Nordisk worth $141K as of Q2 2026.
Knights of Columbus Asset Advisors sold 1,562 Novo Nordisk shares in Q2 2026, an estimated $67.1K.
Novo Nordisk made up 0.01% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #355 holding.
Knights of Columbus Asset Advisors first reported a position in Novo Nordisk in Q2 2023 and has held it in 13 quarters since.
Knights of Columbus Asset Advisors's Novo Nordisk position peaked at $502K in Q3 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.